{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreiccq3knf45euivg3lniywn6r22wdl442jkshfijeoc53zovd6cbli",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mftppar6hxs2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreibwbvlmwoktjhv2svcxvcwjwjub77efi7lxb573xtajy6paa7ko2a"
    },
    "mimeType": "image/jpeg",
    "size": 257145
  },
  "path": "/news/2026-02-patients-atrial-fibrillation-higher-common.html",
  "publishedAt": "2026-02-27T07:20:01.000Z",
  "site": "https://medicalxpress.com",
  "tags": [
    "Medications"
  ],
  "textContent": "Patients with atrial fibrillation who are prescribed diltiazem to control heart rate alongside anticoagulants (blood thinners) such as apixaban or rivaroxaban face a higher risk of serious bleeding compared with those taking metoprolol, according to a new study from Vanderbilt Health researchers and colleagues at the Perelman School of Medicine.",
  "title": "Patients with atrial fibrillation face higher bleeding risks when treated with 2 common medications"
}